Certolizumab pegol in severe rheumatoid arthritis: Real-world evidence in an Argentine cohort: Achievement of targets (T2T) at 3 months and predictive factors.
Article in Global Rheumatology (February 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Global Rheumatology (February 2024)
Article in Global Rheumatology (February 2024)
Article in Global Rheumatology (February 2024)